• Hartalega released proxy Q&A ahead of its shareholder meeting on Sept. 3, 2026, outlining operating, pricing, cost, and risk priorities.
• Utilization ran at 96% of active capacity, excluding hibernated Plants 3 and 4; Plant 9 lifted active capacity to about 28 billion pieces.
• No profit sensitivity given for lower utilization; earnings would hinge on ASPs, mix, raw materials, FX, and fixed-cost absorption.
• U.S. represented about 67% of sales volume; tariff shifts could reshape pricing and flows, with competitiveness also tied to quality and compliance.
• Gross margin improved to about 12.7%; cost actions delivered RM 47.1 million savings, while Q1 FY2027 posted RM 80 million operating profit, RM 70.1 million PAT.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Hartalega Holdings Bhd published the original content used to generate this news brief on September 03, 2026, and is solely responsible for the information contained therein.